Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2025
Imaging of Adrenal Masses.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Delaney Francis T, Chung Ryan, Blake Michael A, Sweeney Ann T
Аннотация
OBJECTIVE: Adrenal lesions are common and require appropriate management when clinically relevant. The approach to the evaluation of an adrenal lesion is to exclude malignancy and hormone excess as these are associated with significant morbidity and mortality.
METHODS: Imaging of adrenal lesions primarily aims to identify features indicating benignity. Noncontrast computed tomography is recommended as first-line imaging for adrenal lesions. Indeterminate lesions that require further characterization may proceed to adrenal protocol computed tomography (with contrast) or magnetic resonance imaging, with a trend in recent years towards increasing use of magnetic resonance imaging. Positron emission tomography-computed tomography may also be used to assess adrenal lesions in certain clinical scenarios.
RESULTS: Clinical guidelines recommend that all adrenal incidentalomas require further dedicated imaging unless they are clearly benign on imaging. The imaging strategy of adrenal lesions depends upon a number of factors including patient history, nature of detection, imaging characteristics (size, heterogeneity, presence of intracellular lipid), and the presence or absence of hormone excess. Special considerations are given to pregnant patients, young patients <40 years, and those with a history of an extra-adrenal malignancy.
CONCLUSION: This review outlines the role of imaging for adrenal lesions, describes the various imaging options and investigation strategies, and highlights relevant imaging findings.
METHODS: Imaging of adrenal lesions primarily aims to identify features indicating benignity. Noncontrast computed tomography is recommended as first-line imaging for adrenal lesions. Indeterminate lesions that require further characterization may proceed to adrenal protocol computed tomography (with contrast) or magnetic resonance imaging, with a trend in recent years towards increasing use of magnetic resonance imaging. Positron emission tomography-computed tomography may also be used to assess adrenal lesions in certain clinical scenarios.
RESULTS: Clinical guidelines recommend that all adrenal incidentalomas require further dedicated imaging unless they are clearly benign on imaging. The imaging strategy of adrenal lesions depends upon a number of factors including patient history, nature of detection, imaging characteristics (size, heterogeneity, presence of intracellular lipid), and the presence or absence of hormone excess. Special considerations are given to pregnant patients, young patients <40 years, and those with a history of an extra-adrenal malignancy.
CONCLUSION: This review outlines the role of imaging for adrenal lesions, describes the various imaging options and investigation strategies, and highlights relevant imaging findings.